Press Releases

July 13, 2017
Publication in Cell Demonstrates Moderna’s Zika mRNA Vaccine Prevents In Utero Transmission of Zika Virus in Mice, Protects Against Zika-Related Congenital Damage
May 03, 2017
Melissa J. Moore, Ph.D., Chief Scientific Officer, mRNA Research Platform at Moderna, Elected to National Academy of Sciences
April 27, 2017
Moderna Announces Positive Interim Phase 1 Clinical Data Demonstrating First mRNA Vaccine Candidate, mRNA-1440, Induces High Levels of Immunogenicity
February 22, 2017
Moderna Appoints Israel Ruiz to its Board of Directors
January 09, 2017
Moderna Provides Pipeline and Full-Year Corporate Update
January 04, 2017
Moderna Joins the Human Vaccines Project to Help Advance Fundamental Understanding of the Immune System
January 03, 2017
Moderna to Highlight its mRNA Development Candidate Pipeline at 2017 J.P. Morgan Healthcare Conference
October 27, 2016
Moderna Therapeutics Named the No. 3 Top Employer by Science Magazine
October 06, 2016
Moderna Appoints Annie Seibold Drapeau as Chief Human Resources Officer
September 21, 2016
Moderna to Build State-of-the-Art Fully Integrated GMP mRNA Clinical Manufacturing Facility in Norwood, Mass.

Media Coverage
June 07, 2017

‘Don’t underestimate Merck’s vaccine business,’ says CEO

May 16, 2017

Meet the 2017 CNBC Disruptor 50 Companies

Wall Street Journal
April 27, 2017

Startup Moderna Shows Promise in Vaccine Trial

Huffington Post
April 21, 2017

The Immunization ‘Innovations of Tomorrow’ Are Here Today

Cell Press
February 17, 2017
More evidence that Zika mRNA vaccines can stop viral replication in mice
February 01, 2017
This mysterious $2 billion biotech is revealing the secrets behind its new drugs and vaccines
January 10, 2017
Moderna Finally Unveils Pipeline at JPM, with 5 Candidates in Testing
EP Vantage
January 10, 2017
JP Morgan – Moderna Comes Out of Stealth Mode
January 09, 2017
Secretive Biotech Unicorn Moderna Unveils Pipeline, Financials
January 09, 2017
Mysterious $5 Billion Biotech Firm Moderna Lays Out Drug Pipeline